Disc Medicine finalised the pivotal Phase III trial design of bitopertin in erythropoietic protoporphyria (EPP) with the FDA earlier this week.
SDOBJS (which stands for Scattered Disc Objects) is a design studio from Piacenza, Italy, founded by architects Bahar Pourmoghadam and Marco Cattivelli, respectively Iranian and Italian. 'The ...